Background {#Sec1}
==========

Insecticide-treated nets (ITN) are highly effective at reducing child mortality and incidence of uncomplicated and severe malaria \[[@CR1]\]. Universal coverage with long-lasting insecticidal nets (LLINs) or indoor residual spraying (IRS) is a fundamental target for the protection of all people at risk of contracting malaria \[[@CR2]\]. Between 2012 and 2014 (3 years), a cumulative total of 427 million LLINs were supplied for use in sub-Saharan Africa, mostly free of charge through mass distribution campaigns \[[@CR3]\]. The rapid scale up of LLIN distribution has resulted in an estimated 49 % (44--54 %) of households in sub-Saharan Africa owning at least one ITN in 2013 compared with only 3 % in 2004 \[[@CR3]\]. Since the launch of the US President's Malaria Initiative in 2005, there has also been a substantial increase in IRS coverage in sub-Saharan Africa, with a peak of 77 million people (11 % of the at risk population) protected by IRS in 2011 \[[@CR4]\]. Recently there has been a decrease in IRS coverage by 29 %, with only 55 million people protected in 2013 \[[@CR3]\].

Pyrethroid insecticides are currently the only insecticides that are recommended by the WHO for use on LLINs \[[@CR5]\]. Pyrethroids have been the chemical of choice for malaria vector control in recent decades but use of pyrethroids in agriculture and scaling up of malaria vector control has resulted in the evolution and spread of pyrethroid resistance in *Anopheles gambiae* sensu lato \[[@CR6]--[@CR8]\]. Target site insensitivity and metabolic resistance mechanisms are now widespread across sub-Saharan Africa and the effectiveness of LLINs and IRS treatment of houses with pyrethroid formulations is under threat \[[@CR6], [@CR9]--[@CR11]\]. IRS formulations of insecticides with a different mode of action to pyrethroids are more costly, which has led to decreasing IRS coverage \[[@CR12]\]. The situation for LLIN is more perilous, with no alternative insecticides currently recommended by WHO Pesticide Evaluation Scheme (WHOPES) for use on mosquito nets \[[@CR5]\]. Cost-effective, safe insecticides with different modes of action to those currently used in public health are urgently needed to sustain the effectiveness of LLINs \[[@CR13]\] and Innovative Vector Control Consortium (IVCC) are working together with industry and research partners to develop new active ingredients for vector control \[[@CR14]\].

Indoxacarb was the first commercialized insecticide of a new class known as the oxadiazines and is highly efficacious against a wide range of agricultural pests \[[@CR15]\] through a novel mode of action \[[@CR16]\]. Indoxacarb was registered in 2000 by the United States Environmental Protection Agency (US EPA) in water dispersible granules (WG) (Avaunt^®^) and emulsifiable concentrate (EC) (Steward^®^) formulations, initially for foliar application targeting lepidopteran pests of cotton, rice, apples, pears, sweet corn, lettuce and fruiting vegetables \[[@CR16], [@CR17]\]. Indoxacarb has more recently been shown to be effective in the control of cockroaches \[[@CR18]\], fire ants \[[@CR19]\], termites \[[@CR20]\], fleas \[[@CR21]\], and houseflies \[[@CR22]\] and has been commercialized as a gel bait (Advion^®^).

Indoxacarb is a neurotoxic insecticide that blocks voltage-dependent sodium channels, resulting in insect paralysis and death \[[@CR15]\]. Despite the sodium channel being a well known target site for DDT and pyrethroids, crucially the mode of action for indoxacarb is distinct from other sodium channel targets \[[@CR23]\]. This is possible due to the sodium channel being structurally large and complex, with at least 9 independent target sites for a variety of neurotoxins \[[@CR24]\]. Indoxacarb is a pro-insecticide which is metabolized into the more active form after entering the insect host \[[@CR16]\]. Bioactivation of indoxacarb (DPX-JW062) through decarbomethoxylation to the more active metabolite (DCJW) is attributed to the action of esterase and amidase enzymes within the insect \[[@CR15], [@CR24]\]. The active metabolite of indoxacarb exerts its effect by blocking the voltage-gated sodium ion channels in insects and is at least forty times more potent than parent indoxacarb in its ability to block sodium channel ion current \[[@CR15], [@CR21], [@CR24]\].

Indoxacarb has proven effective as a broad spectrum oral insecticide against a wide variety of agricultural pests \[[@CR17]\] but few studies have evaluated indoxacarb as a contact insecticide for vector control. Testing of indoxacarb treated polyester netting in Benin using WHO standard three minutes cone bioassay against *An. gambiae* showed a positive mortality dose--response, with dosages \>100 mg/m^2^ producing mortality above the WHOPES threshold of 80 % \[[@CR25], [@CR26]\]. Tunnel test simulators using host-seeking mosquitoes confirmed good efficacy in terms of mortality at dosages \>100 mg/m^2^, but there was no protection in terms of blood-feeding inhibition \[[@CR25]\]. Time to first take-off testing demonstrated that even at a high dosage of 500 mg/m^2^ indoxacarb was only a mild irritant to *An. gambiae* and probably explains the lack of blood-feeding inhibition in tunnel tests \[[@CR25]\]. Of critical importance was the lack of cross-resistance through mechanisms offering resistance to pyrethroids; no difference was found between the mortality rates for susceptible and pyrethroid resistant strains of *An. gambiae* \[[@CR25]\]. The different target site on the sodium channel means that cross-resistance to existing pyrethroid or DDT target site-based resistance mechanisms is unlikely \[[@CR24]\]. Indeed, strains of important crop pests the fall armyworm, *Spodoptera frugiperda*, and the diamondback moth, *Plutella xylostella*, which exhibit high levels of resistance to pyrethroids, showed no cross-resistance to indoxacarb \[[@CR27], [@CR28]\].

A LLIN that reduces the longevity of *Anopheles* mosquitoes but does not protect from biting can be a successful strategy at high coverage rates through a mass insecticidal effect \[[@CR29]\]. An alternative strategy is to combine a non-repellent insecticide (to provide high levels of mortality) in a mixture with a pyrethroid insecticide (to provide protection against blood-feeding through repellency) \[[@CR30]\]. In this study, indoxacarb was tested in bioassays and tunnel simulators as a single treatment and in a mixture with the pyrethroid alphacypermethrin against *An. gambiae* and *Culex quinquefasciatus* (pyrethroid susceptible and resistant strains) to determine its performance in terms of mortality and blood-feeding inhibition.

Methods {#Sec2}
=======

Insecticide formulations {#Sec3}
------------------------

Bioassay testing was conducted in parallel at three Pan-African Malaria Vector Research Consortium (PAMVERC) trial sites in Moshi and Muheza, Tanzania, and in Cotonou, Benin, during the course of a project with DuPont and Innovative Vector Control Consortium (IVCC). One hundred denier polyester netting was treated at PAMVERC trial sites with indoxacarb suspension concentrate (SC) 14.5 % or alphacypermethrin SC 2 % (DuPont, Wilmington, DE, USA). A tank mix was prepared at the field stations to treat netting with a mixture of the two insecticides.

Toxicology {#Sec4}
----------

Indoxacarb has an excellent safety profile for mammals and is classified by US-EPA as 'reduced risk' \[[@CR17]\]. Indoxacarb has a WHO toxicological classification II (moderately hazardous), an LD50 oral toxicity in rats of 268 mg/kg body weight and is category 3 under the Globally Harmonized System of Classification (GHS) \[[@CR31]\]. This category is the same as the pyrethroid insecticides permethrin and deltamethrin, which are the most commonly used insecticides for LLINs \[[@CR31], [@CR32]\]. Mammals exhibit minimal bioactivation of indoxacarb to the more active metabolite, and the active metabolite has much weaker potency against mammalian sodium channels than insect sodium channels and is extensively metabolized and eliminated in the urine \[[@CR33]\]. Indoxacarb has no known adverse impact on beneficiary insects \[[@CR17], [@CR24]\].

Efficacy of indoxacarb ITN against *Anopheles gambiae* and *Culex quinquefasciatus* in tunnel tests {#Sec5}
---------------------------------------------------------------------------------------------------

The tunnel test is a standard WHOPES specified laboratory system designed to allow expression of behavioural interactions that occur between free-flying mosquitoes and ITNs. Tunnel tests were carried out as a forerunner to experimental hut trials, as they provide information on dosage-dependent repellency, blood-feeding inhibition, mortality, and insecticide mixture interactions. Tunnel dimensions and protocols were as described in WHOPES guidelines for evaluation of ITN \[[@CR34]\]. In one of the chambers, a guinea pig was housed unconstrained in a small wooden cage, and in the other chamber 50 unfed adult female *An. gambiae* of the pyrethroid susceptible Kisumu strain, aged 3--5 days, were released at dusk and left overnight. The netting surface was 400 cm^2^ and nine 1-cm diameter holes were cut into it (one hole located at the centre of the square, and the other eight holes equidistant and located 5 cm from the border) to give opportunity for mosquitoes to pass into the baited chamber. The following morning, live mosquitoes were removed from the chambers and held in paper cups under controlled conditions (25--27 °C and 75--85 % RH, with access to sugar solution), and monitored for delayed mortality for an additional 72 h after removal from the chamber.

In the first experiment netting samples treated with indoxacarb at dosages of 100, 500, and 1000 mg/m^2^ were tested against the pyrethroid susceptible strain *An. gambiae* Kisumu. Three replicates of 50 (n = 150) *An. gambiae* Kisumu mosquitoes per treatment were tested compared to an untreated control. In the second experiment efficacy of netting samples treated with indoxacarb at 500 mg/m^2^ was compared with alphacypermethrin at 20 and 40 mg/m^2^, based on the WHOPES recommended dosage range \[[@CR35]\], against pyrethroid susceptible *Cx. quinquefasciatus* TPRI and resistant *Cx. quinquefasciatus* Muheza strains. Three replicates of 50 females were conducted for each treatment (n = 150) and strain. The *Cx. quinquefasciatus* Muheza strain was originally sampled from coastal Tanzania and colonized in the early 1990s but have since been selected with permethrin at the larval stage and is highly pyrethroid resistant in WHO cylinder tests (0.05 % permethrin papers, mortality = 15 %, n = 200). The use of the synergists PBO and DEF in bottle bioassays has demonstrated the presence of metabolic mechanisms of resistance in this strain (Matowo, personal communication).

Efficacy of ITN mixture (indoxacarb + pyrethroid) against pyrethroid resistant *Cx. quinquefasciatus* in tunnel tests and bioassays {#Sec6}
-----------------------------------------------------------------------------------------------------------------------------------

Efficacy of single treatments and mixtures of indoxacarb 25--300 mg/m^2^ and alphacypermethrin 25 mg/m^2^ was determined in tunnel tests. Two replicates of 50 (n = 100) pyrethroid resistant *Cx. quinquefasciatus* Cotonou strain were tested per treatment. In addition, a standard 3-min WHO wire-ball bioassay was conducted on the same netting samples with 4 replicates of 10 mosquitoes per sample (n = 40).

Ethical approval {#Sec7}
----------------

Ethical approval was granted from the Tanzania National Institute of Medical Research (NIMR/HQ/R.8c/Vol.I/24) and London School of Hygiene and Tropical Medicine Ethics Committee (Application no. 5162).

Results {#Sec8}
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Efficacy of indoxacarb ITN against *Anopheles gambiae* and *Culex quinquefasciatus* in tunnel tests {#Sec9}
---------------------------------------------------------------------------------------------------

Mosquito netting treated with 500 or 1000 mg/m^2^ indoxacarb exceeded the WHOPES threshold of 80 % mortality (after 72 h) in tunnel tests (Table [1](#Tab1){ref-type="table"}). Mortality rates were relatively low immediately after overnight exposure and there was delayed mortality up to 72 h after exposure. Unfed mosquitoes accounted for 96 % of the mortality that did occur immediately after overnight exposure across all dosages of indoxacarb. Treatment of netting with indoxacarb (100--1000 mg/m^2^) reduced mosquito penetration by approximately 40 % regardless of dosage (P \> 0.05), and conferred protection by inhibiting between 60 and 75 % of blood-feeding (Table [1](#Tab1){ref-type="table"}).Table 1Dosage testing of indoxacarb treated mosquito netting in tunnel tests against *Anopheles gambiae* KisumuInsecticide (mg/m^2^)Mortality (%)Penetration (%)Blood-feeding (%)Blood-feeding inhibition (%)Immediate24 h48 h72 hUntreated7^a^7^a^7^a^7^a^78^a^73^a^NAIndoxacarb 10046^b^55^b^60^b^65^b^48^b^26^bc^64Indoxacarb 50031^c^68^c^79^c^85^c^47^b^18^b^75Indoxacarb 100045^b^73^c^86^c^91^c^51^b^29^c^60If the superscript is the same in a column there was no significant difference between treatments

Alphacypermethrin-treated ITNs at 40 mg/m^2^ killed a far greater proportion of pyrethroid susceptible (78 % mortality) than resistant (21 % mortality) *Cx. quinquefasciatus* (P \< 0.001) (Table [2](#Tab2){ref-type="table"}). Indoxacarb-treated ITN (500 mg/m^2^) was equally effective against pyrethroid susceptible (67 % mortality) and resistant *Cx. quinquefasciatus* (75 % mortality) (P = 0.092). Indoxacarb (75 % mortality) was far more effective at killing pyrethroid resistant *Cx. quinquefasciatus* than was alphacypermethrin 40 mg/m^2^ (21 % mortality) (P \< 0.001). Indoxacarb ITN (500 mg/m^2^) reduced blood-feeding by 100 and 76 % against the TPRI and Muheza strains respectively and equalled the performance of alphacypermethrin 20 mg/m^2^ (P \> 0.05).Table 2Comparison of indoxacarb and pyrethroid treated mosquito netting in tunnel tests against pyrethroid susceptible and resistant *Culex quinquefasciatus*Insecticide (mg/m^2^)Mortality (%)Penetration (%)Blood-feeding (%)Blood-feeding inhibition (%)Immediate24 h48 h72 h*Culex quinquefasciatus* TPRI (pyrethroid susceptible) Untreated0^a^1^a^8^a^11^a^57^a^53^a^NA Alphacypermethrin 2050^b^52^b^59^b^59^b^13^b^1^b^98 Alphacypermethrin 4068^c^69^c^78^c^78^c^12^b^0^b^100 Indoxacarb 50042^b^54^b^63^b^67^b^3^c^0^b^100*Culex quinquefasciatus* Muheza (pyrethroid resistant) Untreated0^a^2^a^3^a^4^a^67^a^62^a^NA Alphacypermethrin 2011^b^22^b^27^b^29^b^34^b^17^b^73 Alphacypermethrin 408^b^17^b^19^b^21^c^7^c^4^c^94 Indoxacarb 5008^b^58^c^66^c^75^d^25^d^15^b^76If the superscript is the same in a column there was no significant difference between treatments (analysed separately by species)

Efficacy of a mixture of indoxacarb and pyrethroid applied to netting against pyrethroid resistant *Culex quinquefasciatus* Cotonou in tunnel tests and bioassays {#Sec10}
-----------------------------------------------------------------------------------------------------------------------------------------------------------------

Netting treated with alphacypermethrin at 25 mg/m^2^ killed only 35 % of pyrethroid resistant *Cx. quinquefasciatus* Cotonou in tunnel tests (Fig. [1](#Fig1){ref-type="fig"}). Indoxacarb ITN at low dosages of 25--100 mg/m^2^ produced low levels of mortality (\<20 %) but indoxacarb ITN at 200 and 300 mg/m^2^ killed 60 and 52 % of mosquitoes respectively. Mixtures always killed a higher proportion than the single treatments, with indoxacarb 200 mg/m^2^ + alphacypermethrin 25 mg/m^2^ killing the highest proportion of mosquitoes (83 % mortality) (Fig. [1](#Fig1){ref-type="fig"}). Ball-frame bioassays using the same netting pieces produced 100 % mortality for indoxacarb samples at 200 and 300 mg/m^2^ but only 13 % mortality for the pyrethroid (Fig. [2](#Fig2){ref-type="fig"}). In tunnel tests, the pyrethroid reduced blood-feeding by 50 % compared to the untreated control (Fig. [3](#Fig3){ref-type="fig"}). Indoxacarb at 200 and 300 mg/m^2^ produced equivalent feeding inhibition at 52 and 54 % respectively (P \> 0.05). Lower dosages of indoxacarb 25--100 mg/m^2^ were less effective than alphacypermethrin (P \< 0.05) and reduced blood-feeding by between 26 and 40 %. Mixtures conferred far greater protection than the single treatments, with all dosages producing levels of blood-feeding inhibition \>80 % (Fig. [3](#Fig3){ref-type="fig"}).Fig. 1Percentage mortality of pyrethroid resistant *Cx. quinquefasciatus* Cotonou from tunnel tests with ITN samples of indoxacarb (indox) + alphacypermethrin (alpha) mixture compared with single treatmentsFig. 2Percentage mortality of pyrethroid resistant *Cx. quinquefasciatus* Cotonou from ball-frame bioassays with a mixture of indoxacarb + alphacypermethrin compared with single treatmentsFig. 3Comparison of netting treated with a mixture of indoxacarb + alphacypermethrin with single treatments in tunnel tests in terms of blood-feeding inhibition against pyrethroid resistant *Cx. quinquefasciatus* Cotonou strain

Discussion {#Sec11}
==========

Pyrethroid resistance has become widespread in malaria vectors throughout sub-Saharan Africa and the lack of alternative insecticides for use on mosquito nets is a particularly serious threat to malaria vector control \[[@CR5], [@CR6]\]. The Global Plan for Insecticide Resistance Management in Malaria Vectors (GPIRM) states that if pyrethroids were to lose most of their efficacy 55 % of the benefits of vector control would be lost, leading to approximately 120,000 deaths not averted \[[@CR36]\]. New insecticides for ITN should ideally reduce the mean life expectancy of *Anopheles* mosquitoes through a mass killing, provide individual user protection through repellency, show no cross-resistance to existing insecticides used for malaria control and be safe for humans and non-target organisms \[[@CR14], [@CR36]\]. Standard WHOPES 3 min ball-frame bioassay produced 100 % mortality (72 h) for dosages of indoxacarb \>100 mg/m^2^, which is well above the threshold of 80 % specified in WHO guidelines for evaluation of LLINs \[[@CR26]\]. Similarly, indoxacarb produced high levels of mortality in tunnel tests against both *An. gambiae* and *Cx. quinquefasciatus* at dosages \>100 mg/m^2^. Although the majority of mortality occurred within 24 h of testing, delayed mortality should routinely be recorded up to 72 h after exposure. Insect species metabolize indoxacarb rapidly to the more active metabolite DCJW after ingestion, but more slowly after topical treatment, thus explaining the delayed mortality \[[@CR15]\]. Indoxacarb is conventionally thought to produce relatively low levels of repellency against mosquitoes \[[@CR25]\] and agricultural pests \[[@CR20]\], however in these studies high levels of blood-feeding inhibition were achieved with *An. gambiae* and *Cx. quinquefasciatus*, particularly at dosages \>100 mg/m^2^. Reduced penetration of holed, indoxacarb treated netting may be indicative of indoxacarb-induced repellency. However, 96 % of *An. gambiae* mosquitoes killed immediately after overnight exposure were unfed, indicating that these were killed rapidly before being able to penetrate the netting and blood-feed. Mixtures of indoxacarb and alphacypermethrin produced particularly impressive levels of blood-feeding inhibition, with an apparent additive effect.

As with any new insecticide, questions must be asked regarding whether cross-resistance might be conferred by mechanisms of insecticide resistance that have developed in field populations of the target species, how rapidly resistance might develop, and which genes might be involved \[[@CR36]\]. Crucially, no cross-resistance has been detected to indoxacarb in a pyrethroid resistant strain of *Cx. quinquefasciatus* or in pyrethroid resistant strains of agricultural pests \[[@CR22], [@CR27], [@CR28]\]. In houseflies, two insectary strains 5900 and 18,000 fold resistant to permethrin showed no cross-resistance to indoxacarb despite the presence of kdr and increased oxidative metabolism mediated by cytochrome P450 CYP6D1 \[[@CR22]\]. The lack of cross-resistance is partly due to the distinctive target site on the sodium channel compared to other insecticides that target sodium channels such as pyrethroids and DDT \[[@CR24]\]. The only record of indoxacarb resistance in wild mosquito populations was reported for *Aedes albopictus* in Pakistan and was attributed to intensive indoxacarb application for the control of cotton pests over several generations and not due to cross-resistance \[[@CR37]\]. Indoxacarb has a solubility in water of 0.20 mg/l at 25 °C which is similar to alphacyano-pyrethroids and pyrrole insecticides \[[@CR38]\]. As with these other classes of insecticide with low water solubility, development of wash resistant formulations for long lasting treatment of mosquito nets should be feasible.

Conclusions {#Sec12}
===========

With the development and spread of resistance to pyrethroids, carbamates, and organophosphate insecticides, new insecticides with different modes of action to those currently used are urgently needed if effective malaria vector control is to be sustained. In this study tunnel tests and bioassays have shown that indoxacarb is highly effective both in terms of mortality against a pyrethroid susceptible strain of *An. gambiae* and against pyrethroid susceptible and resistant strains of *Cx. quinquefasciatus* and in reducing the amount of blood-feeding by these mosquito strains. Indoxacarb appears to be particularly promising when deployed as a mixture with a pyrethroid and should be evaluated in experimental hut trials against wild free-flying, pyrethroid resistant *An. gambiae* and with wash-resistant formulations.
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